首页> 外文期刊>BMC Genomics >Epistasis analysis of microRNAs on pathological stages in colon cancer based on an?Empirical Bayesian Elastic Net method
【24h】

Epistasis analysis of microRNAs on pathological stages in colon cancer based on an?Empirical Bayesian Elastic Net method

机译:基于经验贝叶斯弹性网法的结肠癌微RNA的上位性分析

获取原文
           

摘要

Background Colon cancer is a leading cause of worldwide cancer death. It has become clear that microRNAs (miRNAs) play a role in the progress of colon cancer and understanding the effect of miRNAs on tumorigenesis could lead to better prognosis and improved treatment. However, most studies have focused on studying differentially expressed miRNAs between tumor and non-tumor samples or between stages in tumor tissue. Limited work has conducted to study the interactions or epistasis between miRNAs and how the epistasis brings about effect on tumor progression. In this study, we investigate the main and pair-wise epistatic effects of miRNAs on the pathological stages of colon cancer ?using datasets from The Cancer Genome Atlas. Results We develop a workflow composed of multiple steps for feature selection based on the Empirical Bayesian Elastic Net (EBEN) method. First, we identify the main effects using a model with only main effect on the phenotype. Second, a corrected phenotype is calculated by removing the significant main effect?from the original phenotype. Third, we select features with epistatic effect on the corrected phenotype. Finally, we run the full model with main and epistatic effects on the previously selected main and epistatic features. Using the multi-step workflow, we identify a set of miRNAs with main and epistatic effect on the pathological stages of colon cancer. Many of miRNAs with main effect on colon cancer have been previously reported to be associated with colon cancer, and the majority of the epistatic miRNAs share common target genes that could explain their epistasis effect on the pathological stages of colon cancer. We also find many of the target genes of detected miRNAs are associated with colon cancer. Go Ontology Enrichment Analysis of the experimentally validates targets of main and epistatic miRNAs, shows that these target genes are enriched for biological processes associated with cancer progression. Conclusion Our results provide a set of candidate miRNAs associated with colon cancer progression that could have potential translational and therapeutic utility. Our analysis workflow offers a new opportunity to efficiently explore epistatic interactions among genetic and epigenetic factors that could be associated with human diseases. Furthermore, our workflow is flexible and can be applied to analyze the main and epistatic effect of various genetic and epigenetic factors on a wide range of phenotypes.
机译:背景技术结肠癌是全世界癌症死亡的主要原因。很明显,microRNA(miRNA)在结肠癌的进展中起作用,了解miRNA对肿瘤发生的作用可以导致更好的预后和改善的治疗。但是,大多数研究都集中在研究肿瘤与非肿瘤样品之间或肿瘤组织各阶段之间差异表达的miRNA。进行有限的工作来研究miRNA之间的相互作用或上位性以及上位性如何对肿瘤进展产生影响。在这项研究中,我们使用癌症基因组图谱中的数据调查了miRNA对结肠癌病理阶段的主要和成对上位作用。结果我们基于经验贝叶斯弹性网(EBEN)方法开发了一个由多个步骤组成的工作流,以进行特征选择。首先,我们使用仅对表型有主要影响的模型来识别主要影响。其次,通过从原始表型中去除显着的主效应来计算校正表型。第三,我们选择对校正表型具有上位性作用的特征。最后,我们对先前选择的主要和上位特征运行具有主要和上位作用的完整模型。使用多步骤工作流程,我们确定了一组对结肠癌的病理阶段具有主要作用和上位作用的miRNA。先前已报道许多对结肠癌具有主要作用的miRNA与结肠癌有关,并且大多数上位性miRNA具有共同的靶基因,可以解释其对结肠癌病理阶段的上位效应。我们还发现检测到的miRNA的许多靶基因与结肠癌有关。 Go Ontology富集分析实验验证了主要和上位miRNA的靶标,表明这些靶标基因丰富了与癌症进展相关的生物过程。结论我们的结果提供了一组与结肠癌进展相关的候选miRNA,可能具有潜在的翻译和治疗用途。我们的分析工作流程提供了一个新的机会,可以有效地探索可能与人类疾病相关的遗传和表观遗传因素之间的上位相互作用。此外,我们的工作流程非常灵活,可用于分析各种遗传和表观遗传因素对广泛表型的主要作用和上位作用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号